Understanding intestinal vulnerability to perforation in the extremely low birth weight infant

Pediatric Research

Volumn 65, Issue 2, 2009, Pages 138-144

  Gordon, Phillip V ^a,b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b Ochsner Children's Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INDOMETACIN; NITRIC OXIDE SYNTHASE; SOMATOMEDIN; STEROID; TRANSFORMING GROWTH FACTOR ALPHA;

CANDIDA; DISEASE PREDISPOSITION; EXTREMELY LOW BIRTH WEIGHT; HISTOPATHOLOGY; HUMAN; INFECTION; INTESTINE MOTILITY; INTESTINE PERFORATION; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; ILEUM; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTESTINAL PERFORATION; NECROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; RUPTURE, SPONTANEOUS; SIGNAL TRANSDUCTION; STEROIDS;

EID: 60449099638     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31818c7920     Document Type: Review

References (57)

1. Ehrlich PF, Sato TT, Short BL, Hartman GE 2001 Outcome of perforated necrotizing enterocolitis in the very low-birth weight neonate may be independent of the type of surgical treatment. Am Surg 67:752-756
2. Moss RL, Dimmitt RA, Barnhart DC, Sylvester KG, Brown RL, Powell DM, Islam S, Langer JC, Sato TT, Brandt ML, Lee H, Blakely ML, Lazar EL, Hirschl RB, Kenney BD, Hackam DJ, Zelterman D, Silverman BL 2006 Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med 354:2225-2234
3. Gordon P, Rutledge J, Sawin R, Thomas S, Woodrum D 1999 Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol 19:573-577
4. Tatekawa Y, Muraji T, Imai Y, Nishijima E, Tsugawa C 1999 The mechanism of focal intestinal perforations in neonates with low birth weight. Pediatr Surg Int 15:549-552
5. Hwang H, Murphy JJ, Gow KW, Magee JF, Bekhit E, Jamieson D 2003 Are localized intestinal perforations distinct from necrotizing enterocolitis? J Pediatr Surg 38:763-767
6. Holland AJ, Shun A, Martin HC, Cooke-Yarborough C, Holland J 2003 Small bowel perforation in the premature neonate: congenital or acquired? Pediatr Surg Int 19:489-494
7. Gordon PV, Swanson JR, Clark R 2008 Antenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC. Am J Obstet Gynecol 198:725
8. Gordon PV, Swanson JR, Attridge JT, Clark R 2007 Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria? J Perinatol 27:661-671
9. Attridge JT, Clark R, Walker MW, Gordon PV 2006 New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations. J Perinatol 26:185-188
10. Attridge JT, Clark R, Gordon PV 2006 New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol 26:667-670
11. Gordon PV, Young ML, Marshall DD 2001 Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 21:156-160
12. Attridge JT, Clark R, Walker MW, Gordon PV 2006 New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 26:93-99
13. Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF, Samuels DP, McAuliffe TL 1999 A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 104:91-99
14. Anttila E, Peltoniemi O, Haumont D, Herring E, ter Horst H, Heinonen K, Kero P, Nykänen P, Oetomo SB, Hallman M 2005 Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomized trial and meta-analysis evaluating the duration of dexamethasone therapy. Eur J Pediatr 164:472-481
15. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ 2001 Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 344:95-101
16. Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA 2005 A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol 25:119-124
17. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M 2005 Pretreatment Cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr 146:632-637
18. Vermont Oxford Network Steroid Study Group 2001 Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 108:741-748
19. Kopelman AE, Moise AA, Holbert D, Hegemier SE 1999A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. J Pediatr 135:345-350
20. Yeh TF, Tone JA, Rastogi A, Anyebuno MA, Pildes RS 1990 Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 117:273-282
21. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, Bader D, Yurman S, Dolfin T, Kuint J, Milbauer B, Kohelet D, Goldberg M, Armon Y, Davidson S, Sirota L, Amitai M, Zaretsky A, Barak M, Gottfried S 1996 Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 74:F33-F37
22. Watterberg KL, Gerdes JS, Gifford KL, Lin HM 1999 Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 104:1258-1263
23. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, Couser RJ, Garland JS, Rozycki HJ, Leach CL, Backstrom C, Shaffer ML 2004 Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114:1649-1657
24. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS 1996 A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 98:204-210
25. Sinkin RA, Dweck HS, Horgan MJ, Gallaher KJ, Cox C, Maniscalco WM, Chess PR, D'Angio CT, Guillet R, Kendig JW, Ryan RM, Phelps DL 2000 Early dexamethasone-attempting to prevent chronic lung disease. Pediatrics 105:542-548
26. Roberts RS 2004 Early closure of the Watterberg trial. Pediatrics 114:1670-1671
27. Jobe AH 2004 Postnatal corticosteroids for preterm infants-do what we say, not what we do. N Engl J Med 350:1349-1351
28. Attridge JT, Herman AC, Gurka MJ, Griffin MP, McGahren ED, Gordon PV 2006 Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations. J Perinatol 26:49-54
29. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC 2005 Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 115:655-661
30. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH 2004 Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:1304-1313
31. Nagaraj HS, Sandhu AS, Cook LN, Buchino JJ, Groff DB 1981 Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg 16:1003-1007
32. Alpan G, Eyal F, Vinograd I, Udassin R, Amir G, Mogle P, Click B 1985 Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 106:277-281
33. Kühl G, Seyberth HW 1986 Intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 108:327-328
34. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, Vincer M 2006 TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 148:730-734
35. Ragouilliaux CJ, Keeney SE, Hawkins HK, Rowen JL 2007 Maternal factors in extremely low birth weight infants who develop spontaneous intestinal perforation. Pediatrics 120:e1458-e1464
36. Coates EW, Karlowicz MG, Croitoru DP, Buescher ES 2005 Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics 116:e241-e246
37. Robertson NJ, Kuna J, Cox PM, Lakhoo K 2003 Spontaneous intestinal perforation and Candida peritonitis presenting as extensive necrotizing enterocolitis. Acta Paediatr 92:258-261
38. Bond S, Stewart DL, Bendon RW 2000 Invasive Candida enteritis of the newborn. J Pediatr Surg 35:1496-1498
39. Adderson EE, Pappin A, Pavia AT 1998 Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg 33:1463-1467
40. Novack CM, Waffarn F, Sills JH, Pousti TJ, Warden MJ, Cunningham MD 1994 Focal intestinal perforation in the extremely-low-birth-weight infant. J Perinatol 14:450-453
41. Meyer CL, Payne NR, Roback SA 1991 Spontaneous, isolated intestinal perforations in neonates with birth weight less than 1,000 g not associated with necrotizing enterocolitis. J Pediatr Surg 26:714-717
42. Mintz AC, Applebaum H 1993 Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg 28:857-860
43. Amin SB, Sinkin RA, Glantz JC 2007 Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 197:486.e1-e10
44. Gordon PV, Price WA, Stiles AD 2001 Dexamethasone administration to newborn mice alters mucosal and muscular morphology in the ileum and modulates IGF-I localization. Pediatr Res 49:93-100
45. Herman AC, Carlisle EM, Paxton JB, Gordon PV 2004 Insulin-like growth factor-I governs submucosal growth and thickness in the newborn mouse ileum. Pediatr Res 55:507-513
46. Gordon PV, Herman AC, Marcinkiewicz M, Gaston BM, Laubach VE, Aschner JL 2007 A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin. J Pediatr Gastroenterol Nutr 45:509-519
47. Gordon PV, Paxton JB, Herman AC, Carlisle EM, Fox NS 2004 Igf-I accelerates ileal epithelial cell migration in culture and newborn mice and may be a mediator of steroid-induced maturation. Pediatr Res 55:34-41
48. Gordon PV, Paxton JB, Kuemmerle JF, Fox NS 2005 A 14-kDa cathepsin L-derived carboxyl IGFBP-2 fragment is sequestered by cultured rat ileal crypt cells. Am J Physiol Gastrointest Liver Physiol 289:G79-G87
49. Gordon PV, Moats-Staats BM, Stiles AD, Price WA 2002 Dexamethasone changes the composition of insulin-like growth factor binding proteins in the newborn mouse ileum. J Pediatr Gastroenterol Nutr 35:532-538
50. Gordon PV, Paxton JB, Fox NS 2005 The cellular represser of E1A-stimulated genes mediates glucocorticoid-induced loss of the type-2 IGF receptor in ileal epithelial cells. J Endocrinol 185:265-273
51. Gordon PV, Price WA, Stiles AD, Rutledge JC 2001 Early postnatal dexamethasone diminishes transforming growth factor alpha localization within the ileal muscularis propria of newborn mice and extremely low-birth-weight infants. Pediatr Dev Pathol 4:532-537
52. Gordon PV, Marshall DD, Stiles AD, Price WA 2001 The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: from the baby's bowel to the researcher's bench. Mol Genet Metab 72:91-103
53. Kajanne R, Leppä S, Luukkainen P, Ustinov J, Thiel A, Ristimäki A, Miettinen PJ 2007 Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine. Pediatr Res 62:570-575
54. Zaman K, Palmer LA, Doctor A, Hunt JF, Gaston B 2004 Concentration- dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and SpI. Biochem J 380:67-74
55. Watterberg K 2005 Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction: in reply. Pediatrics 115:1447
56. Bloom BT 2006 Attridge et al. present an analysis of a complex data set, which offers important confirmation of the differences between the clinical presentation of spontaneous intestinal perforations (SIP) and surgical necrotizing enterocolitis (see author reply). J Perinatal 26:384-386
57. Ohlsson A, Walia R, Shah S 2008 Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 23:CD003481